Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative
- Rania Abdel-latif*
- , Wadha Al Muftah
- , Shaban Mohammed
- , Toka AlHsson
- , Daoud Al-Badriyeh
- , Radja Badji
- , Awad Al-Qahtani
- , Abdul Rahman Arabi
- , Said Ismail
- , Moza Al Hail
- , Jassim Al Suwaidi
*Corresponding author for this work
- Qatar Foundation HQ
- Hamad Medical Corporation
- College of Pharmacy
Research output: Contribution to journal › Article › peer-review